BioIVT Leukomax Halfpak Leukopaks are optimized to deliver a high concentration of single-donor peripheral blood mononuclear cells (PBMCs), with a rich mixture of T cells, B cells, NK cells, and monocytes and minimal granulocyte or red blood cell contamination. As a critical starting material for manufacturing and research, Leukomax provides the high cell count and viability necessary for consistent results in downstream applications.
Features and Benefits
Consistency: High cell viability and purity to minimize variability in process development and manufacturing.
Characterization: Available with specific HLA typing, viral status, and demographic criteria to match precise study cohorts.
Continuity: Access to a reliable network of recallable donors, allowing for longitudinal studies or repeat collections from the same source.
Scalability: Large single-donor volumes available to support scaling from research bench to clinical trials.